Anebulo Pharmaceuticals Q3 EPS $(0.06) Beats $(0.12) Estimate
Anebulo Pharmaceuticals Q3 EPS $(0.06) Beats $(0.12) Estimate
Anebulo Pharmaceuticals第三季度每股收益美元（0.06美元）超過預期（0.12美元）
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.12) by 50 percent. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year.
Anebulo Pharmicals（納斯達克股票代碼：ANEB）公佈的季度虧損爲每股0.06美元，比分析師普遍預期的0.12美元（0.12美元）高出50％。與去年同期的每股虧損（0.11）美元相比，增長了45.45％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。